课题基金 / 基金详情

Efficacy of the monoclonal antibodies and their mechanism of transmission-blocking activitiesof Plasmodium yoelii in Anopheles stephensi.

Efficacy of the monoclonal antibodies and their mechanism of transmission-blocking activitiesof Plasmodium yoelii in Anopheles stephensi.
史氏按蚊约氏疟原虫单克隆抗体的功效及其阻断传播活性的机制。
批准号:
07670279
负责人:
TORII Motomi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

TORII Motomi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The monoclonal antibodies (mAb) against Plasmodium yoelii zygote and ookinete have been shown to block infectivity of the parasites to mosquitoes. We have studied the efficacy of the mAbs and their mechanism of transmission-blocking activities. The transmission-blocking effect of mAb 4 against P.yoelii zygote/ookinete 28 kD protein (Pys28) was complete in Anopheles stephensi. Moreover, the blockade of mAb 4 was stronger than that of mAb 10 against P.yoelii zygote/ookinete 22 kD protein (Pys22). Monoclonal antibody 4 inhibited the zygote formation and mAb 10 suppressed the maturation of zygotes to ookinetes in mosquito midgut in 4-15h after blood meal. In vitro experiment showed that both 28 kD and 22 kD determinants were already present in the cytoplasm of gametocytes, and early zygotes (approx.30 min post-culture) expressed a protein of Mr 28 kD or 22 kD in their cytoplasm and synthesized on their surface for 2-24h or 4-24h post-culture respectively. The onset of surface expression of Pys28 was earlier than Pys22. Fab fragments of mAb 4 had transmission-blocking activity in mice. Fab fragments of mAb 10 did not have detectable transmission-blocking effect, although F (ab')_2 did. These data suggest that mAb 4 and mAb 10 cause suppression of oocyst development in the complement and antibody-dependent cell-mediated cytotoxicity, and that mAb 4 might prevent the function of the target surface protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
  • 批准号:
    20H03480
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.32万
  • 财政年份:
    2020
  • 负责人:
    TORII Motomi
  • 依托单位:
Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
  • 批准号:
    16H05816
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.32万
  • 财政年份:
    2016
  • 负责人:
    TORII Motomi
  • 依托单位:
Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
  • 批准号:
    15H04725
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.98万
  • 财政年份:
    2015
  • 负责人:
    TORII Motomi
  • 依托单位:
Development of novel malaria transmission blocking vaccine
  • 批准号:
    21406010
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.23万
  • 财政年份:
    2009
  • 负责人:
    TORII Motomi
  • 依托单位:
国内基金
海外基金
GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
户外杀蚊真菌农药研制(GC Malaria)
  • 批准号:
    82261128004
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    150.00万元
  • 批准年份:
    2022
  • 负责人:
    彭国雄
  • 依托单位:
GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
  • 批准号:
    82261128006
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    130.00万元
  • 批准年份:
    2022
  • 负责人:
    张东京
  • 依托单位:
GC Malaria:高效实时户外疟疾媒介蚊虫诱捕监测技术和装置的研发
  • 批准号:
    82261128003
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    150.00万元
  • 批准年份:
    2022
  • 负责人:
    陈晓光
  • 依托单位: